Fawdon Manufacturing Centre ( SF ) Pharmaceutical Import Profile — United Kingdom (DGFT 2022–2026)

Name: Fawdon Manufacturing Centre ( SF ) Pharmaceutical Import Records from India — 3 Products, $5.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Fawdon Manufacturing Centre ( SF ) — Pharmaceutical Importer Profile (2026) | 3 Products, $5.7M Trade | TransData Nexus

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ras	Ayurvedic & Herbal Products	$3.8M	76	0.4%	12
2	Simvastatin	Cardiovascular	$986.5K	47	0.8%	7
3	Voriconazole	Advanced Antifungals	$881.3K	25	2.8%	5

Fawdon Manufacturing Centre ( SF ) imports 3 pharmaceutical products across 3 categories into United Kingdom totaling $5.7M.

Fawdon Manufacturing Centre ( SF ) — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Fawdon Manufacturing Centre (SF) is a pharmaceutical importer and buyer based in the United Kingdom. The company specializes in importing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily sourced from India. These products are distributed across various therapeutic categories, with a notable emphasis on Ayurvedic and herbal products, cardiovascular medications, and advanced antifungals. The company's operations are integral to the UK's pharmaceutical supply chain, ensuring the availability of a diverse range of medicines to meet domestic healthcare needs.

2Distribution Network

Fawdon Manufacturing Centre (SF) operates a distribution network that encompasses multiple warehouse locations within the United Kingdom. While specific details about the number and geographic spread of these warehouses are not publicly disclosed, the company's strategic positioning in Newcastle upon Tyne suggests a focus on serving both regional and national markets. The logistics capabilities are designed to facilitate efficient importation and distribution of pharmaceutical products, ensuring timely delivery to various healthcare providers and retailers across the UK.

3Industry Role

In the United Kingdom's pharmaceutical supply chain, Fawdon Manufacturing Centre (SF) functions primarily as a pharmaceutical importer and buyer. The company sources finished pharmaceutical formulations from international suppliers, particularly from India, and distributes these products within the UK market. By focusing on the importation of finished dosage forms, SF plays a crucial role in enhancing the diversity and availability of pharmaceutical products, thereby contributing to the overall resilience and competitiveness of the UK's healthcare sector.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Fawdon Manufacturing Centre ( SF )

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Fawdon Manufacturing Centre (SF) exhibits a high degree of sourcing concentration, importing a limited number of products from a select group of suppliers. This strategy may be driven by the desire to establish strong, long-term relationships with key manufacturers, ensuring consistent product quality and supply reliability. However, such concentration also introduces potential risks, including vulnerability to supply chain disruptions or changes in supplier dynamics. The company's import data indicates a significant volume of shipments from a few suppliers, suggesting a strategic choice to maintain close partnerships. This approach necessitates robust risk management strategies to mitigate potential impacts on the supply chain.

2Supply Chain Resilience

The resilience of Fawdon Manufacturing Centre (SF)'s supply chain is closely tied to its sourcing practices. By relying heavily on a limited number of suppliers, particularly from India, the company may face challenges related to supply chain disruptions, such as geopolitical tensions, regulatory changes, or logistical issues. To enhance resilience, SF could consider diversifying its supplier base and incorporating alternative sourcing strategies. Additionally, evaluating the regulatory compliance and quality standards of key suppliers is essential to ensure consistent product quality and mitigate potential risks associated with supply chain vulnerabilities.

Importing Pharmaceuticals into United Kingdom — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Kingdom

1Regulatory Authority & Framework

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) serves as the primary regulatory authority overseeing pharmaceutical imports. The MHRA is responsible for ensuring that all medicines and medical devices meet appropriate standards of safety, quality, and efficacy. Key legislation governing pharmaceutical imports includes the Human Medicines Regulations 2012, which transposes EU directives into UK law, and the Medicines Act 1968. The marketing authorization pathway for Indian generics involves obtaining a UK marketing authorization, either through the national procedure or the European centralized procedure, ensuring that imported generics meet the necessary regulatory standards for sale in the UK.

2Import Licensing & GMP

Import licensing requirements in the UK stipulate that all pharmaceutical products must be authorized by the MHRA before being placed on the market. This includes obtaining a wholesale distribution authorization for entities involved in the importation and distribution process. Good Manufacturing Practice (GMP) certification is a critical component of the import licensing process. The MHRA recognizes GMP certificates from the European Union (EU GMP), the World Health Organization (WHO GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Indian exporters seeking to supply Fawdon Manufacturing Centre (SF) must ensure that their manufacturing facilities hold valid GMP certifications recognized by the MHRA to comply with UK import regulations.

Fawdon Manufacturing Centre ( SF ) — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Fawdon Manufacturing Centre (SF)'s focus on importing Ayurvedic and herbal products, cardiovascular medications, and advanced antifungals aligns with current market demands in the UK. The growing interest in alternative and complementary medicines has increased the demand for Ayurvedic and herbal products. Cardiovascular diseases remain a leading health concern, driving the need for effective treatments. Advanced antifungals are essential in managing complex fungal infections, particularly in immunocompromised patients. By concentrating on these therapeutic areas, SF addresses critical healthcare needs and positions itself strategically within the UK's pharmaceutical market.

2Sourcing Profile

Fawdon Manufacturing Centre (SF) employs a sourcing strategy that emphasizes importing finished pharmaceutical formulations from India. This approach leverages India's robust pharmaceutical manufacturing sector, known for producing high-quality generics at competitive prices. The focus on finished dosage forms allows SF to offer a diverse product portfolio without the complexities associated with raw material sourcing and manufacturing. India's compliance with international GMP standards and its recognized certifications facilitate the importation process, ensuring that SF's products meet the regulatory requirements of the UK market.

Market Positioning

Seller's Guide — How to Become a Supplier to Fawdon Manufacturing Centre ( SF )

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Fawdon Manufacturing Centre (SF), particularly if they can offer products that align with SF's focus on Ayurvedic and herbal products, cardiovascular medications, and advanced antifungals. To capitalize on this opportunity, Indian exporters should ensure that their products meet the quality standards and regulatory requirements of the UK market, including holding recognized GMP certifications. Additionally, demonstrating the ability to supply consistent volumes and maintain reliable delivery schedules will be crucial in establishing a successful partnership with SF.

2Requirements & Qualifications

Indian exporters seeking to supply Fawdon Manufacturing Centre (SF) and the UK market must obtain marketing authorization from the MHRA, ensuring that their products meet UK safety, quality, and efficacy standards. Manufacturing facilities must hold valid GMP certifications recognized by the MHRA, such as EU GMP, WHO GMP, or PIC/S. Products must comply with UK labeling requirements, including English language labeling and adherence to serialization mandates. Additionally, exporters should be prepared to undergo batch testing and stability assessments to confirm product quality and shelf-life.

Frequently Asked Questions — Fawdon Manufacturing Centre ( SF )

What products does Fawdon Manufacturing Centre ( SF ) import from India?

Fawdon Manufacturing Centre ( SF ) imports 3 pharmaceutical products across 3 categories. Top imports: Ras ($3.8M), Simvastatin ($986.5K), Voriconazole ($881.3K).

What is Fawdon Manufacturing Centre ( SF )'s total pharmaceutical import value?

Fawdon Manufacturing Centre ( SF )'s total pharmaceutical import value from India is $5.7M, based on 148 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Fawdon Manufacturing Centre ( SF ) focus on?

Fawdon Manufacturing Centre ( SF ) imports across 3 categories. The largest: Ayurvedic & Herbal Products (67.0%), Cardiovascular (17.4%), Advanced Antifungals (15.5%).

Get Full Fawdon Manufacturing Centre ( SF ) Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Fawdon Manufacturing Centre ( SF )

Fawdon Manufacturing Centre ( SF ) — Import Portfolio & Supplier Network

What Products Does Fawdon Manufacturing Centre ( SF ) Import?

Top Products by Import Value

Fawdon Manufacturing Centre ( SF ) Therapeutic Categories — 3 Specializations